Hereditary Cancer in Clinical Practice · Nov 18, 2026
Yield of urinary tract cancer surveillance among patients with Lynch syndrome
By Trivedi M, Godil A, Lee M et al.
Background: Genitourinary (GU) cancers are associated with Lynch Syndrome (LS), but surveillance is not consistently recommended or routine. Our aim was to evaluate the yield of urinalysis (UA) and urine cytology-based GU cancer surveillance among LS patients. Methods: We conducted a retrospective, single center, registry-based study of LS patients. Demographic characteristics, exposure to GU surveillance, and test performance characteristics were analyzed using descriptive statistics. Results: Among 278 LS patients, 36.7% ( n = 102) underwent ≥ 1 GU surveillance episodes. 55.9% ( n = 57) received UA alone and 44.1% ( n = 45) received UA and cytology. 30.4% (31/102) had at least one positive test and three were diagnosed with GU cancer. 178 UAs and 71 urine cytologies were completed. Per test positivity rates were 23.6% for UA, 16.9% for cytology and 36.6% for concurrent testing. Follow-up CT urography and/or cystoscopy occurred after 89% of positive tests. Positive predictive value for GU cancer was 5.6% for UA, 22.2% for cytology and 10% for concurrent testing. False positive rates were 94.4% for UA, 77.8% for cytology and 90% for concurrent testing. Conclusion: GU surveillance in LS generates frequent positive tests with many false positives. Although cancers were detected, including at early stages, surveillance strategies require refinement to better balance positivity and yield.